期刊文献+

蛋白芯片法联检心力衰竭患者血中细胞因子的意义 被引量:1

Significance of united detection of cytokines in patients with chronic heart failure with protein chips
原文传递
导出
摘要 目的:同步联检慢性心力衰竭(CHF)患者血中9种细胞因子浓度并探讨其临床意义。方法:运用蛋白芯片技术联检64例慢性心力衰竭患者及40例健康对照组血清或血浆中的9种细胞因子含量,选择其中3种细胞因子与经典的酶联免疫双抗体夹心吸附实验(ELISA法)对照。结果:ELISA法和蛋白芯片法联检细胞因子相关性较好,2种方法同时检测血清中基质金属蛋白酶-9(MMP-9)及可溶性CD40L(sCD40L)水平,差异无统计学意义(P>0·05);CHF组与对照组比较:血清中的MMP-9、sCD40L、C-反应蛋白、心脏型脂肪酸结合蛋白及白细胞介素-6、血浆中的BNP前体N-终端、可溶性血管细胞黏附分子-1(sVCAM-1)、内皮素-1和白细胞介素-8浓度升高,差异有统计学意义(P<0·01,P<0·05);随着心功能级别的升高,患者血清中的MMP-9、sCD40L水平明显升高,心功能Ⅳ级>Ⅲ级>Ⅱ级(P<0·01),心功能Ⅳ级与心功能Ⅱ+Ⅲ级患者的sVCAM-1比较,差异有统计学意义(P<0·05);血中MMP-9、sCD40L及sVCAM-1浓度与心功能分级显著正相关(r=0·640,r=0·818,r=0·845,P<0·001),随着心功能下降程度的增加,血中MMP-9、sCD40L及sVCAM-1水平明显升高(P<0·01,P<0·05)。结论:CHF患者血中9种细胞因子水平异常,其中MMP-9、sCD40L、sVCAM-1浓度与心功能的严重程度密切相关,提示上述细胞因子参与和促进不同病因CHF的发生、发展。 Objective: To explore the significance of united detection of nine-cytokines in patients of chronic heart failure(CHF) with protein chips. Method:In view of united detection of serum or plasma levels of 9 cytokines in 64 CHF cases and 40 health cases as control. Result:Levels of serum MMP-9 and sCD40L by protein chip were well correlated to that of by ELISA( P 〉0.05). The levels of serum MMP-9, sCD40L, H-FABP, CRP, IL-6, and plasma NT-proBNP,sVCAM-1 ,ET-1 , IL-8 in the CHF cases were much higher than those of the control cases ( P 〈0.05, P 〈0.01). The levels of serum MMP-9, sCD40L, sVCAM-1 increased significantly in CHF cases with the increased grades of cardiac function, and the levels of serum MMP-9, sCD40L were much higher in NYHA Ⅳ than those of NYHA Ⅲ( P 〈20.05). The levels of serum MMP-9,sCD40L were much higher in NYHA Ⅲ than those of NYHA Ⅱ ( P 〈20.05). The level of sVCAM-1 was much higher in NYHA Ⅳ than that of in NYHA Ⅱ + Ⅲ Levels of serum MMP-9,sCD40L and plasma sVCAM-1 had positive relationship with grades of cardiac function( r =0. 640, r =0. 818, r =0. 845, P〈0.01). The levels of serum MMP-9,sCD40L and plasma sVCAM- 1 increased significantly in CHF cases with the increased grades of cardiac function. Conclusion:The levels of circulating 9 cytokines are abnormal and they may play a pathogenic role in the development and progression of CHF. Levels of MMP-9, sCD40L, and sVCAM-1 have closely relationship with cardiac function status, they may play a pathogenic role in the development and progression of CHF.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2006年第10期603-606,共4页 Journal of Clinical Cardiology
关键词 心力衰竭 蛋白质抗体芯片 细胞因子 Heart failure Protein chips Cytokines
  • 相关文献

参考文献11

  • 1廖玉华.心血管病与炎症及自身免疫机制[J].临床心血管病杂志,2003,19(4):193-193. 被引量:13
  • 2DINARELLO C A, POMERANTS B J. Proinflammatory cytokines in heart failure [J]. Blood Purrif, 2001,19:314-321. 被引量:1
  • 3POUSSET F, ISNARD R, LECHAT P, et al. Prognostic value of plasma endothelin-linpatients with chronic heart failure[J]. Eur Heart J , 1997, 18:254-258. 被引量:1
  • 4LOPPNOW H, WERDAN K, WERNER C. The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed inpatients treated with β-adrenoceptor antagonist [J]. Auton Autacoid Pharmacol,2002 ,22:83-92. 被引量:1
  • 5ABOU-RAYA S, NAIM A, MARZOUK S. Cardiac matrix remodelling in congestive heart failure: the role of matrix metalloproteinases [J]. Clin Invest Med, 2004,27:93-100. 被引量:1
  • 6KOTOWICZ K, DIXON G I, KLEIN N J, et al. Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of kymphocyte[J]. Immunology, 2000, 100:441-444. 被引量:1
  • 7UELAND T, AUKRUST P, YNDESTAD A, et al. Soluble CD40 ligand in acute and chronic heart failure[J]. Eur Heart J, 2005, 26:1101 - 1107. 被引量:1
  • 8YIN W H, CHEN J W, JENA H L,et al. The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure [J]. Eur J Heart Fail, 2003,5:507-516. 被引量:1
  • 9HOBBS F D R, DAVIA R C, ROALFE A K, et al. Reliability of N-terminal probrain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community population [J]. BMJ,2002,324 : 1498-1498. 被引量:1
  • 10GOTO T,TAKASE, H,TORIYAMA, T, et al. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure[J]. Heart, 2003,89:1303-1307. 被引量:1

二级参考文献8

  • 1[1]Bettencourt P, Ferreira A, Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology, 2000, 93: 19-25. 被引量:1
  • 2[2]Pemberton CJ, Johnson ML, Yandle TG, et al. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension, 2000,36: 355-359. 被引量:1
  • 3[3]Hammerer-Lercher A, Neubauer E, Muller S, et al. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta, 2001, 310: 193-197. 被引量:1
  • 4[4]Groenning BA, Nilsson JC, Sondergaard L, et al. Detection of left ventricular enlargement and impaired systolic function with plasma N terminal pro brain natriuretic peptide concentrations. Am Heart J, 2002,143: 923-929. 被引量:1
  • 5[5]Campbell DJ, Mitchelhill KI, Schlicht SM, et al. Plasma a mino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction. J Card Fail, 2000, 6:130-139. 被引量:1
  • 6[6]Jernberg T, Stridsberg M, Venge P, et al. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol, 2002, 40: 437-445. 被引量:1
  • 7[7]Nilsson JC,Groenning BA,Nielsen G, et al. Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide. Am Heart J, 2002,143: 696-702. 被引量:1
  • 8[8]Hobbs FD, Davis RC, Roalfe AK, et al. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ, 2002, 324:1498. 被引量:1

共引文献25

同被引文献16

  • 1毛华,文美,朱晋坤,陈晶晶,李羚,刘庭筑.应用蛋白芯片联合检测急性冠状动脉综合征患者循环血中蛋白标志物[J].中国循环杂志,2006,21(6):426-430. 被引量:1
  • 2MacBcath G. Protein microarrays and proteomics. Nat Genet,2002,32:526-532. 被引量:1
  • 3Wilson D, Nock S. Recent development in protein microarray technology, Angew Chem,2003,42:494-500. 被引量:1
  • 4Robinson W,DiGennaro G, Hueber W,et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med, 2002,8 : 295-301. 被引量:1
  • 5Emili AQ. Cagney G. Large scale functional analysis using peptide or protein arrays. Nature Biotechnology, 2000, 18:393-397. 被引量:1
  • 6Weinberger SR, Dalmasso EA, Fung ET. Current achievements using protein chip array technology. Curr Opin Chem Biol, 2002,6: 86-91. 被引量:1
  • 7Lin SR, Tseng FG, Huang HM, et al. Microsized protein arrays immobilized by microstamps and micro wells for disease diagnosis and drug screening. Fresenius J Anal Chem, 2001, 371:202- 208. 被引量:1
  • 8Guzey C,spigset O. Genotyping of drug targets: a method to predict adverse drug reactions. Drug Saf,2002,25:553-560. 被引量:1
  • 9Srinivas PR, Srivastava S, Hanash S,et al. proteomics in early detection of cancer. Clin Chem,2001,47:1901-1911. 被引量:1
  • 10Bacarese-Hamiltom T, Ardizzoni A, Gray J, et al. Protein arrays for serodiagnosis of disease. Methods Mol Biol, 2004, 264:271-274. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部